Press release
CRBSI Treatment Market Expected to Reach USD 2.2 Billion by 2030 | Persistence Market Research
CRBSI Treatment Market
Among the various segments, antibiotic-based treatments hold the largest share, while the echinocandin antifungal segment is expected to grow rapidly due to the rising incidence of fungal CRBSI cases. North America dominates the market, owing to its advanced healthcare infrastructure and stringent infection control measures, whereas East Asia is expected to register the highest growth rate due to increased healthcare investments and an aging population.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/33952
Key Highlights from the Report
The CRBSI treatment market is projected to grow at a CAGR of 5.7% from 2023 to 2030.
Antibiotics, especially vancomycin, remain the leading treatment option for CRBSI.
The echinocandin segment is witnessing rapid growth, driven by the increasing prevalence of fungal infections.
Hospital pharmacies dominate the distribution channels, but online pharmacies are gaining traction.
North America leads the market, followed by Europe, while East Asia shows the fastest growth.
Innovative catheter technologies with antimicrobial coatings are a significant market opportunity.
Market Segmentation
The CRBSI treatment market is segmented based on drug class, route of administration, indication type, and distribution channels.
By Drug Class:
Antibiotics, particularly vancomycin, hold the largest share due to their effectiveness in treating bacterial infections. Echinocandins are emerging as a high-growth segment due to their efficacy against fungal CRBSI cases.
By Route of Administration:
Injectables dominate the market, offering rapid treatment for bloodstream infections. However, oral formulations are expected to witness high growth, driven by patient convenience and improved treatment protocols.
By Indication Type:
Bacterial infections remain the largest indication segment due to the high prevalence of Gram-positive bacterial CRBSI cases. Fungal infections, though less common, are growing rapidly, driving demand for specialized antifungal treatments.
By Distribution Channel:
Hospital pharmacies account for the majority of sales, given the critical nature of CRBSI cases. However, online pharmacies are expanding quickly, offering greater accessibility to patients.
Regional Insights
North America: Market Leader
North America dominates the CRBSI treatment market due to well-established healthcare infrastructure, stringent regulatory frameworks, and high awareness levels among healthcare professionals. The U.S., in particular, sees high adoption rates for advanced antimicrobial treatments.
East Asia: Fastest-Growing Region
East Asia, led by China and Japan, is experiencing the highest market growth due to increasing healthcare investments, an aging population, and improved access to advanced treatments. Rising cases of chronic diseases requiring catheter use further drive demand.
Market Dynamics
Market Drivers
Increasing prevalence of chronic illnesses, such as cancer and kidney diseases, necessitating catheter use.
Technological advancements in catheter design, including antimicrobial coatings.
Rising healthcare expenditures improving access to better treatment options.
Market Restraints
Growing antibiotic resistance, making treatment more challenging and expensive.
High treatment costs, limiting accessibility in certain regions.
Regulatory hurdles and compliance challenges in drug approvals.
Market Opportunities
Development of antimicrobial-coated catheters to prevent infections.
Expansion of telemedicine and online pharmacies, increasing access to CRBSI treatments.
Investment in novel antibiotic and antifungal drug development to combat resistant bacterial strains.
Frequently Asked Questions (FAQs)
->How big is the global CRBSI treatment market?
->Who are the key players in the CRBSI treatment market?
->What is the projected growth rate of the CRBSI treatment market?
->What is the market forecast for 2032?
->Which region is estimated to dominate the industry through the forecast period?
Company Insights
Key Players in the CRBSI Treatment Market
Pfizer Inc.
Merck & Co., Inc.
Novartis AG
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
AstraZeneca plc
Recent Market Developments
Pfizer announced new clinical trials focused on developing next-generation antibiotics targeting drug-resistant CRBSI strains.
Merck & Co. introduced an advanced antifungal therapy aimed at reducing fungal CRBSI cases in immunocompromised patients.
The CRBSI treatment market is on a robust growth trajectory, fueled by technological advancements, increasing catheter use, and growing awareness of infection control. With ongoing research and development efforts, the industry is set to witness significant innovation and expansion in the coming years.
Contact Us:
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CRBSI Treatment Market Expected to Reach USD 2.2 Billion by 2030 | Persistence Market Research here
News-ID: 3929319 • Views: …
More Releases from Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for CRBSI
CRBSI Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment A …
DelveInsight's, "Catheter-related Bloodstream Infection -Pipeline Insight, 2025," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Catheter-related Bloodstream Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that over five key companies are actively…
Global CRBSI Treatment Market to Experience Significant Growth to reach USD 2,90 …
The global CRBSI treatment market is on a significant growth trajectory, projected to experience a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. This growth is being propelled by multiple factors, including the rising burden of hospital-acquired infections (HAIs), increased use of central venous catheters (CVC), and continual advancements in antimicrobial therapies. These key drivers, along with ongoing innovations in infection prevention and management, are expected to…
CRBSI Treatment Market Expansion on Track to Hit US$ 2.2 Bn by 2030, Says Persis …
The catheter-related bloodstream infection (CRBSI) treatment market is witnessing steady growth, driven by the rising prevalence of healthcare-associated infections (HAIs), the increasing use of intravascular catheters, and growing awareness about infection prevention protocols. With hospitals and healthcare providers under pressure to reduce infection rates and improve patient outcomes, the market for CRBSI treatments-including antibiotics, catheters, and preventive solutions-is evolving rapidly.
✅ Get a Sample Copy of Research Report (Use Corporate…
Catheter-Related Bloodstream Infection (CRBSI) Drugs Market Size, Share, Growth, …
Global Catheter-Related Bloodstream Infection (CRBSI) Drugs Market to Witness Substantial Growth by 2031
The global market for Catheter-Related Bloodstream Infection (CRBSI) drugs has shown remarkable growth in recent years, reaching US$ million in 2022. According to the latest industry analysis, this market is projected to surge to US$ million by 2031, with a robust Compound Annual Growth Rate (CAGR) of during the forecast period spanning 2024 to 2031.
CRBSI is…
Catheter-related bloodstream infection (CRBSI) Market Insight, Epidemiology and …
Catheter-related bloodstream infection (CRBSI) Market research report is the new statistical data source added by Infinity Business Insights.
CRBSIs (central venous catheter-related bloodstream infections) are a leading source of hospital-acquired illness, with high rates of morbidity, death, and expense. The severity of the consequences is determined by the organisms involved, the underlying pre-morbid states, the timeliness, and the suitability of the treatment/interventions received.
Note – In order to provide more accurate…
Catheter-related bloodstream infection (CRBSI) Market Insight, Epidemiology and …
Catheter-related bloodstream infection (CRBSI) Market research report is the new statistical data source added by Infinity Business Insights.
CRBSIs (central venous catheter-related bloodstream infections) are a leading source of hospital-acquired illness, with high rates of morbidity, death, and expense. The severity of the consequences is determined by the organisms involved, the underlying pre-morbid states, the timeliness, and the suitability of the treatment/interventions received.
Note – In order to provide more accurate…
